-
TODAY! The Doctors and Clinicians Preview Period for CMS’ Quality Payment Program (QPP) performance information, closes at 5pm-PST. Medicare News/CMS News
-
A final report on strategies to improve patient safety and reduce medical errors has been delivered to Congress by the U.S. Department of Health and Human Services. National News
-
Patient advocates are invited to apply for a scholarship to attend the upcoming ASCO GI Cancers Symposium. Affiliate Association News/ASCO News
|
|
As we are approaching the end of the year, I am pleased to announce the following updates.
MOASC website
The Clinical Trial Database: The MOASC Clinical Trial Committee is actively looking for ways to assist its members with Clinical Trial promotion and recruitment, through the creation of a database for both physicians and patients https://www.moasc.org/clinical-trials/. If you are interested in adding your clinical trials to the database, please contact me at neast@moasc.org
Inaugural Lung Cancer Webinar Series
Engage in lively discussion and review the latest updates in the management of lung cancer. This one-hour webinar will be held once a month to review a particular topic within this ever more differentiated area of oncology. Dr. Hatim Hussain, Assistant Professor of Medicine at USCD, will moderate the series and will be joined by one to two experts. Our first webinar, scheduled for January 26, 2022, will focus on the management of metastatic EGFR mutated non-small cell lung cancer. Register at moasc@moasc.org. Click here for the full schedule.
Save-the-Date - Saturday, March 26, 2022
MOASC’s 7thAnnual Oncology Summit & Research Symposium on Personalized Medicine for Today and Tomorrow. Includes keynote presentation on “Cancer Cell Map Initiative” by Trey Ideker, PhD, UCSD and Co-Director, NCI Cancer Cell Map Initiative (CCMI) followed by Key opinion leaders highlighting advances as well as Clinical Trials in their respective fields of Breast, CART-T/Transplant, GI, GU, Lung, and Myeloma. If you have any questions or would like more information, please feel free to contact the office at moasc@moasc.org or phone 909-985-9061, ext. 1.
We look forward to having you participate in our lively and informative 2022!
Best wishes for your holidays.
Nichole A. East, CAE
MOASC Executive Director
|
|
MOASC Programs - Save the Dates - All Times are Pacific
|
|
January 26, 6:00pm- MOASC Lung Cancer Webinar Series “Management of Metastatic EGFR Mutated Non-Small Cell Lung Cancer," moderated by Hatim Husain, M.D., Associate Professor of Medicine at USCD, he will be joined by two expert discussants; Jonathan Goldman, M.D., UCLA and Ravi Salgia, M.D., City of Hope.
|
|
Cedars Sinai presents their 22nd Annual Educational Meeting in Gastroenterology, February 25-26, 2022. This two-day virtual activity is intended for gastroenterologists and all other healthcare professionals who treat patients with gastrointestinal disorders. In addition to lecture format presentations, the course will include the following interactive virtual instructional formats: debate and panel discussions, Q & A sessions, case discussions, and interactive video presentations.
|
|
MOASC is pleased to join Rockpointe in presenting an on-demand, free CME/CE-certified webcourse available to MOASC members. The on-demand webcourse will be on “Nonmelanoma Skin Cancers: Current and Emerging Checkpoint Inhibitors for Treating Advanced Basal Cell and Squamous Cell Carcinomas,” and available to anyone who would like to participate until August of 2022. Members are provided with at least 3 opportunities on or around; December 1, 2021, March 1, 2022, July 1, 2022.
|
|
Career News
A premier comprehensive cancer center in Bakersfield, California is seeking two qualified Hematologist-Oncologist for employed positions. This is a wonderful opportunity to join a rapidly growing private practice that is connected to major academic hospitals in southern California. Great income potential: base compensation plus RVU production bonus; comprehensive benefits, including health, vacation time, 401(k), CME days, and 8 national holidays. Interested candidates please email Deb Fogel, COO at dfogel@cbccusa.com or call 661-322-2206.
Thank you!
|
|
The Medical Board of California is reminding prescribers of the upcoming e-prescribing requirements established by Assembly Bill (AB) 2789 (Wood, 2018). Beginning January 1, 2022, most prescriptions (including but not limited to prescriptions for controlled substances) issued by a licensed healthcare practitioner to a California pharmacy must be submitted electronically.
|
|
Effective November 25, 2021, Billing and Coding: MolDX: Oncotype DX Breast Cancer for DCIS (Genomic Health) - R1 has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
|
|
Effective January 02, 2022, MolDX: Minimal Residual Disease Testing for Cancer Final LCD has completed the Open Public Meeting and is now finalized under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV). Responses to comments received may be found as a link at the bottom of the final LCD.
|
|
December 21- Top Denials and Solutions Q4 Webinar
This webinar is intended for Medicare Part B Providers and will include: • Claim Denials • Electronic Data Interchange (EDI) • Medical Necessity • Medicare Secondary Payer (MSP) • Duplicate Claims • Provider Call Inquiries • Medical Review • Resources.
|
|
TODAY! The Doctors and Clinicians Preview Period for CMS’ Quality Payment Program (QPP) performance information, closes on December 14, 2021 at 5pm Pacific. This period provides an opportunity for doctors and clinicians to review their 2020 Quality Payment Program (QPP) performance information before it is publicly reported on clinician and group profile pages on Medicare Care Compare and in the Provider Data Catalog.
|
|
CMS will provide your MAC with files for the automated payments of Health Professional Shortage Area (HPSA) bonuses for dates of service from January 1, 2022, through December 31, 2022. Make sure your billing staff knows about this update.
|
|
The December 9, 2021, CMS MLN Connects has made their latest edition available, with the update to Medicare Deductible Coinsurance and Premium rates for Calendar Year 2022.
|
|
A final report on strategies to improve patient safety and reduce medical errors has been delivered to Congress by the U.S. Department of Health and Human Services in consultation with the Agency for Healthcare Research & Quality. Required by the Patient Safety and Quality Improvement Act of 2005, the report was made available for public review and comment and review by the National Academy of Medicine. It outlined several strategies to accelerate progress in improving patient safety, including using analytic approaches in patient safety research, measurement and practice improvement to monitor risk; implementing evidence-based practices into real-world settings through clinically useful tools and infrastructure; encouraging the development of learning health systems that integrate continuous learning and improvement in day-to-day operations; and encouraging the use of patient safety strategies as outlined in the National Action Plan.
|
|
The American Hospital Association and the American Medical Association filed a lawsuit seeking changes to an HHS rule requiring arbitrators to ignore billed charges in favor of median in-network rates when settling medical billing disputes between insurers and out-of-network health care professionals. The lawsuit asserts that the rule contravenes congressional intent, and basing decisions on median in-network rates would "prevent fair and adequate compensation."
|
|
UnitedHealthcare policy and protocol update has been published.
|
|
Affiliate Association News |
|
On December 2nd ANCO launched their annual election via election runner. All eligible voting members were sent voting instructions via email. The election will remain open until 11:55pm on December 31st. If you did not receive your information, please contact Courtney at courtney@anco.org
Dec. 16, at 12:15 p.m. Pacific, you are invited to ANCO’s Virtual Roundtable & Networking Series, Finding Meaning for Healthcare Professionals, featuring BJ Miller, M.D., noted author, speaker & educator. Dr. Miller has been interviewed by Oprah Winfrey, NPR’s Terry Gross, the New York Times and others, and his 2015 TED Talk, “Not Whether But How,” has been viewed more than 11 million times.
|
|
ANCO's Medicare Update 2022 will be hosted online on Monday, January 10th.
|
|
Cancer Research Saves LivesTM, so can you. Conquer Cancer funds research to help cancer patients conquer cancer. You can make a difference in improving care for every cancer patient, everywhere. Help Conquer Cancer fund more researchers. For a limited time only, gifts matched dollar-for-dollar up to $50,000!
|
|
Patient advocates are invited to apply for a scholarship to attend the upcoming ASCO GI Cancers Symposium in person, taking place January 20-22 at Moscone West, in San Francisco, California. The application period is now open and will close THIS Friday, December 10, at 2pm Pacific. You can download the eligibility and criteria now or view on the first page of the application. We apologize for the quick turn-around time and greatly appreciate your flexibility.
|
|
Save The Date! The 2022 ASCO Annual Meeting, being held June 3-7 in Chicago, IL and online, so you can attend however is most convenient for you.
|
|
Abstracts submitted for oral and poster presentations at the 63rd ASH Annual Meeting & Exposition represent important research in the field and are considered the best of the thousands of abstracts submitted. Six new abstracts highlighting novel and high-impact studies whose results were not available by the general abstract submission deadline have just been released! Begin browsing the late-breaking abstracts, and make sure to tune in to the special late-breaking abstracts session on Tuesday, December 14, at 6am Pacific time.
|
|
Registration is now open for the only official Highlights of ASH in North America. If you are unable to attend the 63rd ASH Annual Meeting in Atlanta, Georgia, or even if you plan to attend and want a refresher on the best science, you won’t want to miss this informative meeting! Join us in Seattle, San Francisco, Washington, DC, Chicago, or New York to get a synopsis of the new advances in patient care and scientific updates presented at this year's annual meeting.
|
|
Get the latest on what is happening in Washington, DC. |
|
Registration is Open! Sign up for the 2022 Community Oncology Conference. You are invited to join thousands of colleagues on March 17-18, 2022, virtually at the Gaylord Palms Hotel in Kissimmee, Florida, for two days of learning and networking. Enjoy early bird pricing through January 20, 2022.
|
|
Leukemia & Lymphoma Society |
|
LLS presents AML Strategies: Decision-making at Each Point in Care, a three-module interactive and recorded series. This three part series will provide members of the multidisciplinary cancer care team with the latest information to improve their knowledge and confidence in the diagnosis and treatment of Acute Myeloid Leukemia (AML) through interactive online activities. Take one, two, or all three modules to earn CE credit.
|
|
BeiGene announced results from a planned interim analysis of the Phase 3 SEQUOIA trial in patients with treatment-naïve (TN) chronic lymphocytic leukemia (CLL), including the randomized Cohort 1 comparing BRUKINSA to bendamustine plus rituximab (B+R) and Cohort 3 (Arm D) of BRUKINSA in combination with venetoclax in patients with deletion of chromosome 17p (del[17p]) and/or pathogenic TP53 variants.
|
|
GRAIL, LLC, announced a partnership with Alignment Health Plan, a national Medicare Advantage health plan from Alignment Healthcare, to provide its Medicare Advantage members access to Galleri®, GRAIL’s groundbreaking multi-cancer early detection blood test. Based in Orange, California, Alignment Health Plan is the first Medicare Advantage plan to offer the Galleri test as a complement to recommended single cancer screenings. New and existing Alignment Health Plan members who enroll in select HMO and PPO plans in California will have access to Galleri beginning Jan. 1, 2022. Galleri is available by prescription only.
|
|
Jazz Pharmaceuticals and PharmaMar announced the initiation of a confirmatory Phase 3 clinical trial, LAGOON, evaluating Zepzelca® (lurbinectedin) for the treatment of patients with relapsed small cell lung cancer (SCLC). The trial will measure overall survival (OS) as the primary endpoint and progression-free survival (PFS) as a secondary endpoint of lurbinectedin monotherapy or lurbinectedin in combination with irinotecan compared with investigator's choice of topotecan or irinotecan, in patients with SCLC whose disease has progressed following prior platinum-containing chemotherapy with or without anti-PD-1 or anti-PD-L1 agents.
|
|
The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care. The material contained in the California Oncology Weekly is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the California Oncology Weekly may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in California Oncology Weekly should not be used as a substitute for such advice. This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein. CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.
|
|
|
|
|
|
|
